WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement today from Scott Melville, president and CEO, regarding the nomination of Dr. Robert Califf as the next U.S. Food and Drug Administration (FDA) commissioner. Dr. Califf is a prominent cardiologist and researcher who served as the FDA commissioner under President Barack Obama. “CHPA
WASHINGTON – The Consumer Healthcare Products Association (CHPA) today launched a new podcast – CHPA Chat – providing stories and insights from staff, industry leaders, academics, and health care providers about the trends and issues facing the consumer healthcare space. Hosting the podcast is Anita Brikman, senior vice president, Communications & Public Affairs, and executive director,
WASHINGTON — The 2019 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released Wednesday showing that the number of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high decreased slightly, coming in at under 3%. When first reported in
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement Wednesday following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R, Ga.) and Bob Casey (D,Pa.): “CHPA thanks Senators Isakson and Casey for reintroducing this important bipartisan legislation which would modernize the regulatory
WASHINGTON — The House Ways and Means Committee on Thursday took an important step toward reinstating consumers’ ability to purchase over-the-counter (O-T-C) medicines with tax-preferred savings accounts, including Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs). The Restoring Access to Medication Act (H.R. 1922), authored by Representatives Ron Kind (D, Wis.), Grace Meng (D
WASHINGTON — The Consumer Healthcare Products Association (CHPA) is hosting its 2nd annual Supply Chain Conference on October 2-3, 2019, at the Royal Sonesta Harbor Court hotel in Baltimore, Md. This year’s conference program was designed to deliver maximum impact in minimal time for senior and mid-level supply chain executives in the over-the-counter pharmaceutical and dietary supplement sectors
WASHINGTON — The Consumer Healthcare Products Association (CHPA) recently appointed Marina Karp as director of health policy, a newly created position responsible for helping to develop the association’s overall health policy priorities including policy research and outreach to the broader health care community. Karp will help lead CHPA’s efforts to educate and engage payers, providers,
WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines
WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America
WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement regarding OTC Eligibility in FSA/HSA Accounts: “CHPA congratulates Representatives Lynn Jenkins (R, Kan.), Ron Kind (D, Wis.), and Grace Meng (D, N.Y.) on the House of Representatives’ passage of H.R. 6199, legislation that will restore consumers’ ability to use their Health Savings Accounts
WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both
WASHINGTON — Changes on the retail scene bode well for the consumer health care products market because they show that chains are trying to stay engaged with their customers, says Consumer Healthcare Products Association (CHPA) chairman and Clarion Brands chief executive officer Gary Downing. “From our perspective it would be more concerning if they were
